Table 1.
Baseline Characteristics by Race
| Race
|
|||
|---|---|---|---|
| White (n=448) | Black (n=68) | p-value | |
|
| |||
| Age (y) | 76.93 ± 7.07 | 75.03 ± 8.37 | 0.045 |
|
| |||
| BMI (kg/m2) | 28.37 ± 4.21 | 28.16 ± 4.07 | 0.70 |
|
| |||
| Orchiectomy at baseline, number (%) | 14 (3.1) | 1 (1.4) | 0.45 |
|
| |||
| Serum PSA, ng/mL | 0.42 ± 0.78 | 0.45 ± 0.92 | 0.76 |
|
| |||
| Prior Years on ADT | 4.34 ± 3.74 | 3.96 ± 2.79 | 0.42 |
|
| |||
| Serum testosterone, ng/dL | 25.61 ± 31.9 | 22.45 ± 5.97 | 0.43 |
|
| |||
| BMD T score | |||
| Lumbar spine | −0.38 ± 1.7 | −0.33 ± 1.9 | 0.85 |
| Total hip | −1.09 ± 1.10 | −0.54 ± 1.1 | 0.001 |
|
| |||
| BMD (g/m2) | |||
| Lumbar spine | 1.11 ± 0.22 | 1.09 ± 0.22 | 0.51 |
| Total hip | 0.91 ± 0.15 | 0.98 ± 0.15 | 0.001 |
|
| |||
| Low BMD any site, number (%) | 356 (79.5) | 44 (64.7) | 0.007 |
|
| |||
| Prevalent vertebral fractures, number (%) | 67 (15) | 5 (7.4) | 0.13 |
|
| |||
| Bone Specific Alk Phos, U/L | 28.28 ± 10.99 | 32.78 ± 10.98 | 0.002 |
|
| |||
| Osteocalcin, ng/mL | 11.29 ± 4.98 | 13.09 ± 5.62 | 0.008 |
|
| |||
| CTX (C-Telopeptide), ng/mL | 0.57 ± 0.25 | 0.70 ± 0.31 | <0.001 |